119 related articles for article (PubMed ID: 10546549)
1. Photodynamic therapy: tumor targeting with adenoviral proteins.
Allen CM; Sharman WM; La Madeleine C; Weber JM; Langlois R; Ouellet R; van Lier JE
Photochem Photobiol; 1999 Oct; 70(4):512-23. PubMed ID: 10546549
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic properties of amphiphilic derivatives of aluminum tetrasulfophthalocyanine.
Allen CM; Langlois R; Sharman WM; La Madeleine C; Van Lier JE
Photochem Photobiol; 2002 Aug; 76(2):208-16. PubMed ID: 12194219
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
4. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754
[TBL] [Abstract][Full Text] [Related]
5. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
[TBL] [Abstract][Full Text] [Related]
6. A non-laser light source for photodynamic therapy: in vitro effects on normal and malignant cells.
Kashtan H; Haddad R; Greenberg R; Skornick Y; Kaplan O
J Med; 2002; 33(1-4):93-104. PubMed ID: 12939108
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
8. Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate.
Dubuc C; Langlois R; Bénard F; Cauchon N; Klarskov K; Tone P; van Lier JE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2424-7. PubMed ID: 18329268
[TBL] [Abstract][Full Text] [Related]
9. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4.
Xue LY; Chiu SM; Oleinick NL
Oncogene; 2001 Jun; 20(26):3420-7. PubMed ID: 11423992
[TBL] [Abstract][Full Text] [Related]
10. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL
Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and phototherapeutic properties of Zinc (II) 2,9,16,23-tetrakis (methoxy) phthalocyanine in vivo.
Yslas EI; Prucca C; Romanini S; Durantini EN; Bertuzzi M; Rivarola V
Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):62-70. PubMed ID: 19447373
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.
Hu M; Brasseur N; Yildiz SZ; van Lier JE; Leznoff CC
J Med Chem; 1998 May; 41(11):1789-802. PubMed ID: 9599230
[TBL] [Abstract][Full Text] [Related]
14. Structure-photodynamic activity relationships of substituted zinc trisulfophthalocyanines.
Cauchon N; Tian H; Langlois R; La Madeleine C; Martin S; Ali H; Hunting D; van Lier JE
Bioconjug Chem; 2005; 16(1):80-9. PubMed ID: 15656578
[TBL] [Abstract][Full Text] [Related]
15. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
[TBL] [Abstract][Full Text] [Related]
16. Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers.
He J; Horng MF; Deahl JT; Oleinick NL; Evans HH
Photochem Photobiol; 1998 Jun; 67(6):720-8. PubMed ID: 9648537
[TBL] [Abstract][Full Text] [Related]
17. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes.
Kyriazi M; Alexandratou E; Yova D; Rallis M; Trebst T
Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):87-94. PubMed ID: 18353089
[TBL] [Abstract][Full Text] [Related]
18. Soybean oil as a possible solubilizing and vehicular medium for zinc phthalocyanine in photodynamic therapy.
Iwunze MO; Ekiko DB
Cell Mol Biol (Noisy-le-grand); 2004 Sep; 50(6):753-8. PubMed ID: 15641167
[TBL] [Abstract][Full Text] [Related]
19. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminium phthalocyanine.
Sutoris K; Vetvicka D; Horak L; Benes J; Nekvasil M; Jezek P; Zadinova M; Pouckova P
Anticancer Res; 2012 Sep; 32(9):3769-74. PubMed ID: 22993318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
